Determinants of early change in serum creatinine after initiation of dolutegravir-based antiretroviral therapy in South Africa.

Autor: Mpofu R; Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, Cape Town, South Africa., Kawuma AN; Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, Cape Town, South Africa., Wasmann RE; Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, Cape Town, South Africa., Akpomiemie G; Ezintsha, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa., Chandiwana N; Ezintsha, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa., Sokhela SM; Ezintsha, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa., Moorhouse M; Ezintsha, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa., Venter WDF; Ezintsha, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa., Denti P; Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, Cape Town, South Africa., Wiesner L; Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, Cape Town, South Africa., Post FA; King's College Hospital NHS Foundation Trust, London, UK., Haas DW; Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA.; Department of Internal Medicine, Meharry Medical College, Nashville, Tennessee, USA., Maartens G; Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, Cape Town, South Africa., Sinxadi P; Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, Cape Town, South Africa.; SAMRC/UCT Platform for Pharmacogenomics Research and Translation (PREMED) unit, Cape Town, South Africa.

Publikováno v: British journal of clinical pharmacology [Br J Clin Pharmacol] 2024 May; Vol. 90 (5), pp. 1247-1257. Date of Electronic Publication: 2024 Feb 08.

Coronavirus Host Genomics Study: South Africa (COVIGen-SA).

Autor: May AK; Sydney Brenner Institute for Molecular Bioscience (SBIMB), Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa., Seymour H; Sydney Brenner Institute for Molecular Bioscience (SBIMB), Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.; Division of Human Genetics, National Health Laboratory Service and School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa., Etheredge H; Wits Donald Gordon Medical Centre, School of Clinical Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.; Steve Biko Centre for Bioethics, School of Clinical Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa., Maher H; Wits Donald Gordon Medical Centre, School of Clinical Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa., Nunes MC; South African Medical Research Council, Vaccines and Infectious Diseases Analytics (VIDA) Research Unit, School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.; Department of Science and Technology, National Research Foundation, South African Research Chair Initiative in Vaccine Preventable Diseases, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa., Madhi SA; South African Medical Research Council, Vaccines and Infectious Diseases Analytics (VIDA) Research Unit, School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.; Department of Science and Technology, National Research Foundation, South African Research Chair Initiative in Vaccine Preventable Diseases, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa., Sokhela SM; Ezintsha, Wits Health Consortium, University of the Witwatersrand, Johannesburg, South Africa., Venter WDF; Ezintsha, Wits Health Consortium, University of the Witwatersrand, Johannesburg, South Africa., Martinson N; Perinatal HIV Research Unit, University of the Witwatersrand, Johannesburg, South Africa.; John Hopkins University Center for TB Research, Baltimore, MD, USA.; Centre for Respiratory Diseases and Meningitis, National Institute for Communicable Diseases and School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa., Nabeemeeah F; Perinatal HIV Research Unit, University of the Witwatersrand, Johannesburg, South Africa.; John Hopkins University Center for TB Research, Baltimore, MD, USA., Cohen C; Division of Infectious Diseases, Department of Internal Medicine, Chris Hani Baragwanath Academic Hospital, University of the Witwatersrand, Johannesburg, South Africa., Moyes J; Division of Infectious Diseases, Department of Internal Medicine, Chris Hani Baragwanath Academic Hospital, University of the Witwatersrand, Johannesburg, South Africa., Walaza S; Division of Infectious Diseases, Department of Internal Medicine, Chris Hani Baragwanath Academic Hospital, University of the Witwatersrand, Johannesburg, South Africa., Tempia S; Division of Infectious Diseases, Department of Internal Medicine, Chris Hani Baragwanath Academic Hospital, University of the Witwatersrand, Johannesburg, South Africa., Kleynhans J; Division of Infectious Diseases, Department of Internal Medicine, Chris Hani Baragwanath Academic Hospital, University of the Witwatersrand, Johannesburg, South Africa., von Gottberg A; Division of Infectious Diseases, Department of Internal Medicine, Chris Hani Baragwanath Academic Hospital, University of the Witwatersrand, Johannesburg, South Africa., Nel J; Department of Medicine, Greys Hospital, Pietermaritzburg, South Africa., Dawood H; Caprisa University of KwaZulu-Natal, Durban, South Africa., Variava E; Klerksdorp-Tshepong Hospital Complex, Klerksdorp, and Department of Medicine, University of the Witwatersrand, Johannesburg, South Africa., Tollman S; MRC/Wits Rural Public Health and Health Transitions Unit (Agincourt), School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa., Kahn K; MRC/Wits Rural Public Health and Health Transitions Unit (Agincourt), School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa., Herbst K; Africa Health Research Institute, Durban, KwaZulu-Natal, South Africa.; Division of Infectious Diseases, University of Alabama at Birmingham, Birmingham, AL, USA., Wong EB; Africa Health Research Institute, Durban, KwaZulu-Natal, South Africa.; Division of Infectious Diseases, University of Alabama at Birmingham, Birmingham, AL, USA., Tiemessen CT; Centre for HIV and STIs, National Institute for Communicable Diseases, and Faculty of Health Sciences, University of Witwatersrand, Johannesburg, South Africa., van Blydenstein A; Division of Pulmonology, Department of Internal Medicine, Chris Hani Baragwanath Academic Hospital, University of the Witwatersrand, Johannesburg, South Africa., Murray L; Department of Medicine, Greys Hospital, Pietermaritzburg, South Africa., Venter M; Department of Medicine, Greys Hospital, Pietermaritzburg, South Africa., Fabian J; Wits Donald Gordon Medical Centre, School of Clinical Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa., Ramsay M; Sydney Brenner Institute for Molecular Bioscience (SBIMB), Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.

Publikováno v: Global health, epidemiology and genomics [Glob Health Epidemiol Genom] 2022 Oct 06; Vol. 2022, pp. 7405349. Date of Electronic Publication: 2022 Oct 06 (Print Publication: 2022).